MGC Pharma has signed a worldwide agreement with European nutraceuticals company Swiss PharmaCan for distribution of its ArtemiC Rescue product as a food supplement.
The deal follows the successful completion of a phase II double-blind, placebo-controlled clinical trial on 50 COVID-19 patients to evaluate the safety and efficacy of ArtemiC Rescue as a treatment in December 2020.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
